SG Americas Securities’s Gilead Sciences GILD Stock Holding History

SG Americas Securities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$188K	Sell	7,300 -534,600	-99%	-$74.9M	﹤0.01%	2670
2025 Q4	$1.23M	Buy	541,900 +374,600	+224%	+$45.5M	﹤0.01%	1844
2025 Q3	$289K	Buy	+167,300	New	+$19M	﹤0.01%	2512
2025 Q2	–	Sell	-13,000	Closed	-$452K	–	3187
2025 Q1	$452K	Hold	13,000	–	–	﹤0.01%	1863
2024 Q4	$248K	Sell	13,000 -250,000	-95%	-$22.5M	﹤0.01%	1952
2024 Q3	$857K	Buy	263,000 +250,000	+1,923%	+$19.1M	﹤0.01%	1203
2024 Q2	$55K	Buy	+13,000	New	+$868K	﹤0.01%	2660
2023 Q3	–	Sell	-220,000	Closed	-$257K	–	3159
2023 Q2	$257K	Sell	220,000 -125,000	-36%	-$9.97M	﹤0.01%	1690
2023 Q1	$1.76M	Sell	345,000 -755,000	-69%	-$62.5M	0.02%	740
2022 Q4	$1.03M	Buy	1,100,000 +293,000	+36%	+$23.2M	0.01%	952
2022 Q3	$398K	Buy	807,000 +40,000	+5%	+$2.52M	﹤0.01%	1750
2022 Q2	$1.77M	Buy	767,000 +750,000	+4,412%	+$46.4M	0.02%	811
2022 Q1	$31K	Buy	+17,000	New	+$1.09M	﹤0.01%	2872
2021 Q1	–	Sell	-61,500	Closed	-$3K	–	3375
2020 Q4	$3K	Hold	61,500	–	–	﹤0.01%	3275
2020 Q3	$23K	Sell	61,500 -150,000	-71%	-$10.4M	﹤0.01%	2559
2020 Q2	$858K	Buy	+211,500	New	+$16.2M	0.01%	1564
2020 Q1	–	Sell	-443,800	Closed	-$147K	–	3527
2019 Q4	$147K	Sell	443,800 -152,500	-26%	-$9.93M	﹤0.01%	2707
2019 Q3	$199K	Buy	596,300 +137,500	+30%	+$8.99M	﹤0.01%	2359
2019 Q2	$688K	Buy	458,800 +165,000	+56%	+$10.9M	﹤0.01%	1690
2019 Q1	$381K	Sell	293,800 -902,400	-75%	-$60M	﹤0.01%	2075
2018 Q4	$646K	Buy	1,196,200 +75,000	+7%	+$5.24M	0.01%	1679
2018 Q3	$3.5M	Buy	1,121,200 +65,000	+6%	+$4.91M	0.03%	734
2018 Q2	$2.64M	Sell	1,056,200 -185,900	-15%	-$13.1M	0.02%	759
2018 Q1	$4.82M	Sell	1,242,100 -42,000	-3%	-$3.34M	0.04%	438
2017 Q4	$2.12M	Sell	1,284,100 -108,600	-8%	-$8.25M	0.02%	844
2017 Q3	$6.42M	Buy	1,392,700 +201,800	+17%	+$15.4M	0.06%	252
2017 Q2	$2.69M	Buy	1,190,900 +687,400	+137%	+$45.7M	0.02%	704
2017 Q1	$633K	Sell	503,500 -468,700	-48%	-$33M	0.01%	1685
2016 Q4	$641K	Buy	972,200 +389,600	+67%	+$29M	0.01%	1552
2016 Q3	$174K	Sell	582,600 -100,000	-15%	-$8.12M	﹤0.01%	2611
2016 Q2	$546K	Buy	682,600 +320,200	+88%	+$28.4M	﹤0.01%	1650
2016 Q1	$1.13M	Sell	362,400 -210,600	-37%	-$19M	0.01%	1235
2015 Q4	$3.98M	Buy	+573,000	New	+$59.6M	0.03%	452
2015 Q3	–	Sell	-654,600	Closed	-$10.1M	–	2326
2015 Q2	$10.1M	Buy	654,600 +424,000	+184%	+$46.3M	0.07%	205
2015 Q1	$3.98M	Sell	230,600 -11,400	-5%	-$1.16M	0.02%	500
2014 Q4	$3.98M	Hold	242,000	–	–	0.02%	687
2014 Q3	$6.28M	Buy	242,000 +99,500	+70%	+$9.74M	0.04%	429
2014 Q2	$2.02M	Sell	142,500 -100,600	-41%	-$7.83M	0.01%	986
2014 Q1	$242K	Buy	243,100 +26,800	+12%	+$2.1M	﹤0.01%	1853
2013 Q4	$3.4M	Sell	216,300 -25,200	-10%	-$1.75M	0.01%	777
2013 Q3	$1.75M	Buy	241,500 +224,300	+1,304%	+$13.4M	0.01%	1002
2013 Q2	$147K	Buy	+17,200	New	+$897K	﹤0.01%	1898

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SG Americas Securities's GILD Position: Q1 2026 in Review

SG Americas Securities reduced its Gilead Sciences (GILD) stake by 24% in Q1 2026, selling an estimated $42.1M and leaving 968,035 shares worth $135M. The position accounts for 0.15% of the portfolio, ranked #115.

SG Americas Securities first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $374M in Q4 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

SG Americas Securities held 968,035 shares of Gilead Sciences worth $135M as of Q1 2026.
SG Americas Securities sold 300,832 Gilead Sciences shares in Q1 2026, an estimated $42.1M.
Gilead Sciences made up 0.15% of SG Americas Securities's portfolio in Q1 2026, its #115 holding.
SG Americas Securities first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
SG Americas Securities's Gilead Sciences position peaked at $374M in Q4 2015.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.